Overview
Organic hallucinosis refers to a syndrome characterized by hallucinations without a primary psychiatric disorder, often associated with underlying metabolic or neurological conditions affecting organic acid metabolism 2.Diagnosis
Measurement of organic acids in urine or blood using advanced techniques such as GC-MS is crucial for diagnosis 1.
Enzyme activity assays in cells may be necessary for definitive diagnosis 1.
Specific metabolic disorders like glutamine synthetase deficiency or pyridoxine-dependent convulsions should be considered in differential diagnosis 2.Management
Treatment focuses on addressing the underlying metabolic disorder; specific enzyme replacement or cofactor supplementation may be indicated based on identified deficiencies 2.
Pyridoxine supplementation is critical for pyridoxine-dependent convulsions, though specific dosing details are not provided 2.
Supportive care including symptomatic treatment for neurological complications is essential 2.Special Populations
No specific guidance provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 12.Key Recommendations
Utilize GC-MS for screening and diagnosis of organic acidurias to identify underlying metabolic causes 1 (Evidence: Moderate).
Consider specific metabolic deficiencies like glutamine synthetase deficiency in the differential diagnosis of organic hallucinosis 2 (Evidence: Moderate).
Provide targeted supplementation or replacement therapy based on identified metabolic deficiencies 2 (Evidence: Weak).References
1 Scott D, Clinton Frazee C, Garg U. Screening of Organic Acidurias by Gas Chromatography-Mass Spectrometry (GC-MS). Methods in molecular biology (Clifton, N.J.) 2022. link
2 Leonard JV. Recent advances in amino acid and organic acid metabolism. Journal of inherited metabolic disease 2007. link